Gelteq Limited (GELS) - Bathi resik saben saham (EPS TTM)

The 12-month rolling earnings per share history on the GURU.Markets chart correlates with Gelteq Limited (GELS) R&D projects aimed at improving the bioavailability of nutraceuticals through gel formulas. Patent monetization and licensing deals allow the company to avoid price competition. The -0.45 indicator expresses the current value of the metric, while the business's financial success depends on regulatory approval of drugs rather than GDP dynamics.

Net income per share serves as a key indicator of return on equity in fundamental analysis. The trend in net income per share over the last 12 months demonstrates the actual efficiency of profit generation per share of ownership. This metric is calculated by dividing the total annual net income by the total number of outstanding shares. For Gelteq Limited (GELS), this figure reflects the commercial success of implementing innovative gel-based drug delivery. The growth of this indicator confirms the scaling demand for alternative forms of medication administration.